PCR amplification on whole blood samples treated with different commonly used anticoagulants

Pediatric Hematology and Oncology

Volumn 23, Issue 6, 2006, Pages 517-521

  Djordjevic, V ^a   Stankovic, M ^a   Nikolic, A ^a   Antonijevic, N ^b   Rakicevic, L ^a   Divac, A ^a   Radojkovic, M ^c  

^a INSTITUTE OF MOLECULAR GENETICS AND GENETIC ENGINEERING   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c Clinical Center Dr Dragisa Misovic   (Serbia)

Author keywords

Anticoagulants; MTHFR C677T; Whole blood PCR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICOAGULANT AGENT; CITRATE SODIUM; DNA; HEPARIN; HEPARIN DERIVATIVE; HEPARIN LITHIUM; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA ISOLATION; EXON; GENE AMPLIFICATION; GENE MUTATION; HUMAN; POLYMERASE CHAIN REACTION;

EID: 33746313197     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010600751900     Document Type: Article

References (6)

1. Gibbs RA, Chamberlain JS, Caskey CT. Diagnostic of new mutation diseases using the polymerase chain reaction. In: Erlich HA, ed. PCR Technology, Principles and applications for DNA amplification. Hants: Macmillan; 1989:171-193.
2. Al-Soud WA, Radstrom P. Purification and characterization of PCR-inhibitory components in blood cells. J Clin Microbiol. 2001;39:485-493.
3. Födinger M, Walter HH, Sunder-Plassman G. Molecular biology of 5,10-methylentetrahydrofolate reductase. J Nephrol. 2000;13:20-33.
4. Frosst P, Blom HJ, Milos R, et al. A candidate gene risk factor for vascular disease: a common mutation in methylene tetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
5. Beutler E, Gelbert T, Kuhl W. Interference of heparin with the polymerase chain reaction. Biotechniques. 1990;9:166.
6. Yokota M, Tatsumi N, Nathalang O, Yamada T, Tsuda I. Effects of heparin on polymerase chain reaction for blood white cells. J Clin Lab Anal. 1999;13:133-140.